The Business of Biologics

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 3845.

Product Description

Biologics are projected to account for more than half of the sales generated by the top 100 products by 2022. Industry experts look at what this shift toward biologics means for the biopharmaceutical industry.

FEEDBACK